Perspective Therapeutics, Inc. (CATX) stock
CATXNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/30
$0.75−0.03 (-3.85%)
Close on Nov 20, 2026Market cap $86.05MP/E –Yield –
Perspective Therapeutics operating margin
Operating margin is operating income as a percentage of revenue.
Perspective Therapeutics's operating margin for the twelve months ending Jun 30, 2022 was -59.5%. For fiscal 2022 it was -59.5%, against -34.3% the year before. The highest annual figure on record is -34.3% in fiscal 2021.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2022 | Jun 30, 2022 | -59.5% | −25.2 |
| FY2021 | Jun 30, 2021 | -34.3% | +1.6 |
| FY2020 | Jun 30, 2020 | -35.9% | +35.9 |
| FY2019 | Jun 30, 2019 | -71.8% | +41.8 |
| FY2018 | Jun 30, 2018 | -113.6% | +18.9 |
| FY2017 | Jun 30, 2017 | -132.5% | −25.9 |
| FY2016 | Jun 30, 2016 | -106.6% | −12.4 |
| FY2015 | Jun 30, 2015 | -94.2% | +14.6 |
| FY2014 | Jun 30, 2014 | -108.7% | −18.9 |
| FY2013 | Jun 30, 2013 | -89.9% | −18.9 |
| FY2012 | Jun 30, 2012 | -71.0% | −14.4 |
| FY2011 | Jun 30, 2011 | -56.6% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | -84.1% | −43.7 |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | -47.3% | −17.8 |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | -58.1% | −21.1 |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | -88.7% | −58.7 |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | -40.3% | +11.8 |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | -29.5% | −10.4 |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | -37.0% | +3.9 |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | -29.9% | +6.2 |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | -52.2% | +7.3 |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | -19.0% | +41.4 |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | -40.9% | +34.1 |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | -36.1% | +61.1 |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | -59.5% | +88.4 |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | -60.4% | +24.7 |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | -75.1% | +20.5 |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | -97.2% | +31.0 |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | -147.8% | −11.8 |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | -85.1% | +23.2 |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | -95.6% | +48.3 |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | -128.2% | +17.5 |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | -136.1% | −24.1 |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | -108.3% | +2.4 |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | -143.9% | −25.3 |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | -145.7% | −59.2 |
| Q4 FY2016CQ2 2016 | Jun 30, 2016 | -112.0% | −29.6 |
| Q3 FY2016CQ1 2016 | Mar 31, 2016 | -110.8% | −20.0 |
| Q2 FY2016CQ4 2015 | Dec 31, 2015 | -118.6% | – |
| Q1 FY2016CQ3 2015 | Sep 30, 2015 | -86.5% | – |
| Q4 FY2015CQ2 2015 | Jun 30, 2015 | -82.4% | – |
| Q3 FY2015CQ1 2015 | Mar 31, 2015 | -90.8% | – |
See a number that looks wrong?